SOURCE: iSatori


December 18, 2012 10:43 ET

iSatori Introduces Belly-Off™ Proprietary Weight-Loss Supplement Through Retailers Nationwide

BioGenetic Laboratories (a Division of iSatori, Inc.) to Launch Unique Proprietary Formula Combination of CLA and YGD™ to Help Dieters Reduce the Appearance of Belly Fat

GOLDEN, CO--(Marketwire - Dec 18, 2012) -  iSatori, Inc. (OTCQB: IFIT) ("the Company") today announced the pending launch of its newest and most anticipated weight-loss supplement called Belly-Off™. The Company's BioGenetic Laboratories division has created several top-selling diet support supplements, and this one, which represents a proprietary combination of clinically tested ingredients, including conjugated linoleic acid (CLA), guarana, yerba mate, and damiana, at their scientifically validated dosages, is designed to help users who battle with excessive belly fat. The Company should commence shipping Belly-Off to customers this month, and the product will be available at select retailers nationwide in January 2013. 

"Three newly published research studies revealed that while losing weight and reducing body fat, especially around the waist, can be very challenging, the process can benefit from daily supplementation of CLA combined with a new weight-loss/energy blend we discovered called YGD™," stated Stephen Adele, Founder and Chief Executive Officer of iSatori, Inc. ( "In all three studies, subjects were shown to lose significantly more body fat than participants who were given a placebo. In one study, none of the participants changed their eating or exercise habits during the trial period, yet those taking the new supplement still lost abdominal fat. Bolstered by these research studies, we anticipate and are gearing up for strong consumer demand for our new Belly-Off product."

Consumers should be aware that Belly-Off may be in short supply (due to the limited availability of some of the ingredients) and has already generated enthusiasm among retailers. Although it should be available on store shelves in January, just to be safe, iSatori is asking consumers to call stores first before visiting them because they expect initial supplies of Belly-Off to sell out quickly. Alternatively, consumers are being directed to the BioGenetic Laboratories website at to purchase Belly-Off or to locate the nearest retailer.

Additional consumer weight-loss support and product information on Belly-Off can be found on the Internet at

Retailers interested in carrying Belly-Off should contact Europa Sports, America's largest sports and health supplement distributor, at 1-800-447-4795 or visit

About iSatori, Inc.

iSatori is a consumer products firm that develops and sells nutritional products through online marketing, Fortune 500 retailers, and thousands of retail stores around the world. The Company is headquartered in Golden, Colorado, and its common stock trades on the OTCQB under the symbol "IFIT." More information about the Company is available at

Forward-Looking Statements

Statements made in this news release relating to the Company's future sales, expenses, revenue, product developments, and all other statements except statements of historical fact, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on assumptions and estimates that management believes are reasonable based on currently available information; however, management's assumptions and the Company's future performance are both subject to a wide range of business risks and uncertainties, and there is no assurance that these goals and projections can or will be met. Any number of factors could cause actual results to differ materially from those in the forward-looking statements, including, but not limited to, the timing and extent of changes in demand for the Company's products, the availability and price of ingredients necessary to manufacture such products, and the outcome of any current or future litigation regarding such products or similar products of competitors. All forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to update any such statement.

Contact Information

  • For additional information, please contact:

    Sue Mosebar
    (303) 215-9174
    Email Contact

    RJ Falkner & Company, Inc.
    Investor Relations Counsel
    (830) 693-4400
    Email Contact